Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Objective This study was performed to investigate the dose-response effects of supplementation with Bifidobacterium animalis subsp lactis (BB-12) and Lactobacillus paracasei subsp paracasei (CRL-431) on blood lipids, recovery from feces and bowel habits. Changes of the fecal microflora was analyzed in the 10(10) CFU/day probiotic and placebo group.Design The study was designed as a randomized, placebo-controlled, double-blinded, parallel dose-response study.Subjects Healthy young adults (18-40 years) were recruited by advertising in local newspapers. Of the 75 persons enrolled, 71 (46 women, 25 men, mean age 25.6 years (range 18-40 years)) completed the study.Intervention The volunteers were randomly assigned into five groups receiving either placebo or a mixture of the two probiotics in the concentration of 10(8), 10(9), 10(10) or 10(11) CFU/day in 2 weeks run-in period, 3 weeks intervention and 2 weeks wash-out. Diary reporting bowel habits and well being (abdominal bloating, flatulence and headache) was kept for all 7 weeks and blood lipids, fecal recovery of BB-12 and CRL-431, as well as fecal microflora was tested before, immediately and 2 weeks after intervention.Results The fecal recovery of BB-12 increased significantly (P < 0.001) with increasing dose. In the group receiving 10(11) CFU/day BB-12 was recovered from 13 out of 15 volunteers. CRL-431 was not recovered in any of the fecal samples. Supplementation with probiotics did not change the fecal bacterial composition. A significant linear increase in fecal consistency (looser stool) with increasing probiotic dose (P = 0.018) was observed. No overall dose-response effect was found on the blood lipids. High doses of probiotics were well tolerated.Conclusion A dose-related recovery of BB-12 from feces was observed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous human studies that have administered other B. lactis strains have successfully confirmed the strain survival by measuring its stool concentration using culture methods and qPCR 6 42 .”
In the citing paper
“This probiotic food has been shown to improve digestive comfort and symptoms in IBS with predominant constipation (IBS-C) (13,14) as well as transit time in both healthy (15 -17) and IBS-C populations (13) .”
In the citing paper
“This probiotic food has been shown to improve digestive comfort and symptoms in IBS with predominant constipation (IBS-C) (13,14) as well as transit time in both healthy (15 -17) and IBS-C populations (13) .”
In the citing paper
“The present study shows that a specific probiotic food that has been shown to improve digestive symptoms in IBS (13,14) is also able to improve GI well-being and digestive symptoms in individuals who do not suffer from GI diseases.”
In the citing paper
“The fermented dairy product used in the present study is also able to decrease transit time in both healthy (15 -17) and IBS populations (13) .”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 124
Research works printed but not linked: 2
- Alm L, Ryd-Kjellen E, Setterberg G, Blomquist L (1993). Effect of a new fermented milk product ‘CULTURA’ on constipation in geriatric patients. First Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press, Norfolk, UK.
- Stahl DA, Devereux R, Amann RI, Flesher B, Lin C, Stromley J (1989). Ribosomal RNA based studies of natural microbial diversity and ecology. In: Hattori T, Ishida Y, Maruyama Y, Morita R, Uchida A (eds). Recent Advances in Microbial Ecology. Japan Scientific Societies Press: Tokyo, Japan, pp 669–673.
Metadata
- Authors
- Larsen, C. N., Nielsen, S., Kæstel, P., Brockmann, E., Bennedsen, M., Christensen, H. R., Eskesen, D. C., Jacobsen, B. L., & Michaelsen, K. F.
- Affiliations
- Chr. Hansen (Denmark) (DK)
- Technical University of Denmark (DK)
- Corresponding author
- Michaelsen, K F
- Venue
- European Journal of Clinical Nutrition
- Published
- 2006-05-24
- Volume
- 60
- Issue
- 11
- Pages
- 1284-1293
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W1972242655
- Cited by
- 124
- References
- 53
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 11 · 2012: 4
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- probiotics, Bifidobacterium animalis subsp. lactis BB-12, dose-response relationship, stool consistency, bowel habits, serum lipids, fecal microbiota, probiotic tolerance, healthy young adults
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Dose-Response Relationship, Drug, Double-Blind Method, Feces, Female, Flatulence, Humans, Lactobacillus, Lipids, Male, Colony Count, Microbial, Dietary Supplements, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. https://app.cochat.ai/papers/10.1038/sj.ejcn.1602450
- The paper
- Larsen, C. N., Nielsen, S., Kæstel, P., Brockmann, E., Bennedsen, M., Christensen, H. R., Eskesen, D. C., Jacobsen, B. L., & Michaelsen, K. F. (2006). Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. European Journal of Clinical Nutrition. https://doi.org/10.1038/sj.ejcn.1602450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.